| |
|
Headlines:
|
 |
Back to Oncology Drug index
Name: Vinblastine Sulfate
Pregnancy Category D
Drug classes
- Mitotic inhibitor
- Antineoplastic agent
Therapeutic actions
Affects cell energy production required for mitosis and interferes with
nucleic acid synthesis; has antimitotic effect and causes abnormal
mitotic figures.
Indications
Palliative treatment for generalized Hodgkin's disease (stages III and
IV), lymphocytic lymphoma, histiocytic lymphoma, mycosis fungoides,
advance testicular carcinoma, Kaposi's sarcoma, Letterer-Siwe disease
Palliative treatment of choriocarcinoma, breast cancer unresponsive to
other therapies
Hodgkin's disease (advanced) alone or in combination therapies
Advanced testicular germinal-cell cancers alone or in combination
therapy
Contraindications/cautions
Contraindicated in the presence of allergy to vinblastine, leukopenia,
acute infection, pregnancy, lactation.
Use caution in the presence of liver disease.
|
|
|
|
Are you a doctor or a nurse?
Do you want to join the Doctors Lounge online medical community?
Participate in editorial activities (publish, peer review, edit) and
give a helping hand to the largest online community of patients.
Click on the link below to see the requirements:
Doctors Lounge Membership
Application |
|
Adverse effects
- CNS: Numbness, paresthesias, peripheral neuritis, mental depression,
loss of deep tendon reflexes, headache, seizures, malaise, weakness,
dizziness
- GI: Nausea, vomiting, pharyngitis, vesiculation of the mouth, ileus,
diarrhea, constipation, anorexia, abdominal pain, rectal bleeding,
hemorrhagic enterocolitis
- Hematologic: Leukopenia
- GU: Aspermia
- Dermatologic: Topical epilation (loss of hair), vesiculation of the skin
- Local: Local cellulitis, phlebitis, sloughing of the skin if
extravasation occurs
- Other: Pain in tumor site Pregnancy Category D
|
|
send
to a friend
printer
friendly version
